Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Age of Onset [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
apnea, obstructive sleep [NCBI] 0.00312698
PARK3 [NCBI] 0.00286011
alzheimer disease 6 [NCBI] 0.00270294
alzheimer disease 5 [NCBI] 0.00243994
alzheimer disease 8 [NCBI] 0.00243994
APOE [NCBI] 0.00226199
PARK10 [NCBI] 0.00205929
epilepsy, myoclonic, benign adult familial, type 1 [NCBI] 0.00201832
RA [NCBI] 0.00182961
VRNI [NCBI] 0.00178455
MAFD6 [NCBI] 0.00172811
prostate cancer, hereditary, 8 [NCBI] 0.00170785
CF [NCBI] 0.00165485
coronary heart disease, susceptibility to, 2 [NCBI] 0.00142616
convulsions, benign familial infantile, 1 [NCBI] 0.00142616
AD14 [NCBI] 0.00142616
AD13 [NCBI] 0.00142616
SCA20 [NCBI] 0.00137197
prostate cancer, hereditary, 9 [NCBI] 0.00137197
IOSCA [NCBI] 0.00127962
AD [NCBI] 0.00127088
PD [NCBI] 0.00114797
PARK6 [NCBI] 0.00104218
ALS3 [NCBI] 0.001012
alzheimer disease 11 [NCBI] 0.001012
IDDM15 [NCBI] 0.001012
MODY [NCBI] 0.000995108
HPCX [NCBI] 0.000927929
EXT3 [NCBI] 0.000852238
ALS5 [NCBI] 0.000852238
CMT2B2 [NCBI] 0.000852238
parkinson disease 12 [NCBI] 0.000852238
amyotrophy, neurogenic scapuloperoneal, new england type [NCBI] 0.000852238
ETL2 [NCBI] 0.000816273
MJD [NCBI] 0.000811115
PSEN1 [NCBI] 0.000798725
SCA2 [NCBI] 0.000775221
ETM2 [NCBI] 0.000744245
CLN4B [NCBI] 0.000744245
restless legs syndrome, susceptibility to, 1 [NCBI] 0.000728802
EKD1 [NCBI] 0.000699323
CMD1Q [NCBI] 0.000685538
FMTLE [NCBI] 0.000685538
major depressive disorder 2 [NCBI] 0.000685538
AD15 [NCBI] 0.000685538
GLC1N [NCBI] 0.000685538
GLC1K [NCBI] 0.000685538
myoclonic epilepsy, infantile [NCBI] 0.000685538
GLC1B [NCBI] 0.000685538
myositis [NCBI] 0.000685538
DFNA25 [NCBI] 0.000685538
polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive [NCBI] 0.000685538
GINGF2 [NCBI] 0.000685538
SPG30 [NCBI] 0.000685538
SPAX2 [NCBI] 0.000685538
EMWX [NCBI] 0.000685538
ETL4 [NCBI] 0.000685538
EJM4 [NCBI] 0.000685538
SPOAN [NCBI] 0.000685538
psoriasis susceptibility 7 [NCBI] 0.000685538
ETM3 [NCBI] 0.000685538
cardioneuromyopathy with hyaline masses and nemaline rods [NCBI] 0.000685538
alzheimer disease 9 [NCBI] 0.000685538
alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology [NCBI] 0.000685538
heart-hand syndrome, slovenian type [NCBI] 0.000685538
myopia 12 [NCBI] 0.000685538
GLC1J [NCBI] 0.000685538
armfield x-linked mental retardation syndrome [NCBI] 0.000685538
SCAR7 [NCBI] 0.000685538
MAFD3 [NCBI] 0.000685538
coronary heart disease, susceptibility to, 3 [NCBI] 0.000685538
DFNA31 [NCBI] 0.000685538
PARK2 [NCBI] 0.000669945
hereditary motor and sensory neuropathy v [NCBI] 0.000662739
CLN4A [NCBI] 0.000662739
HD [NCBI] 0.000655318
MYMY1 [NCBI] 0.000597537
FTD [NCBI] 0.000576308
EIG [NCBI] 0.0005367
MDD [NCBI] 0.00052871
SCA7 [NCBI] 0.000515347
SCA6 [NCBI] 0.00049153
PARK7 [NCBI] 0.000460888
IS1 [NCBI] 0.000453552
GLC1A [NCBI] 0.000431109
HDL3 [NCBI] 0.000425699
DFNA7 [NCBI] 0.000425699
CCAL1 [NCBI] 0.000425699
MPD3 [NCBI] 0.000425699
convulsions, benign familial infantile, 2 [NCBI] 0.000425699
IDDM8 [NCBI] 0.000425699
IDDM6 [NCBI] 0.000425699
GLC1I [NCBI] 0.000425699
CMT2G [NCBI] 0.000425699
DYT13 [NCBI] 0.000425699
diabetes mellitus, noninsulin-dependent, 4 [NCBI] 0.000425699
SPG14 [NCBI] 0.000425699
restless legs syndrome, susceptibility to, 2 [NCBI] 0.000425699
alzheimer disease 7 [NCBI] 0.000425699
melanoma, cutaneous malignant, 4 [NCBI] 0.000425699
WDM [NCBI] 0.000422365
MAFD1 [NCBI] 0.000421308
DRPLA [NCBI] 0.000412788
PARK2 [NCBI] 0.000411169
SCA1 [NCBI] 0.00040987
alzheimer disease 3 [NCBI] 0.000379233
FEB1 [NCBI] 0.000363128
MCKD1 [NCBI] 0.000363128
SLE [NCBI] 0.000339581
thrombocytopenic purpura, autoimmune [NCBI] 0.000332363
cataract, central saccular, with sutural opacities [NCBI] 0.000330974
IDDM13 [NCBI] 0.000330974
cataract, autosomal recessive, early-onset, pulverulent [NCBI] 0.000330974
asthma-related traits, susceptibility to, 6 [NCBI] 0.000330974
auditory neuropathy, autosomal dominant, 1 [NCBI] 0.000330974
CHDS8 [NCBI] 0.000330974
IBD6 [NCBI] 0.000330974
prostate cancer, hereditary, 3 [NCBI] 0.000330974
IDDM11 [NCBI] 0.000330974
zinc, elevated plasma [NCBI] 0.000330974
IDDM3 [NCBI] 0.000330974
IDDM18 [NCBI] 0.000330974
GLC1M [NCBI] 0.000330974
CMD1F [NCBI] 0.000330974
PAND1 [NCBI] 0.00031475
HPC1 [NCBI] 0.000294973
PSEN2 [NCBI] 0.000294512
ALS4 [NCBI] 0.000289017
SPG4 [NCBI] 0.000288342
EA4 [NCBI] 0.000271345
spinal muscular atrophy, distal, congenital nonprogressive [NCBI] 0.000271345
MPD2 [NCBI] 0.000271345
MYP3 [NCBI] 0.000271345
CTAA2 [NCBI] 0.000271345
arrhythmogenic right ventricular dysplasia, familial, 6 [NCBI] 0.000271345
AXPC1 [NCBI] 0.000271345
LGMD1D [NCBI] 0.000271345
CARASIL [NCBI] 0.000271345
SCZD5 [NCBI] 0.000271345
MG [NCBI] 0.000262887
BRCA1 [NCBI] 0.000256492
EGF [NCBI] 0.000245294
SPG3A [NCBI] 0.000241384
alexander disease [NCBI] 0.000239225
myoclonic dystonia [NCBI] 0.00023641
MYOC [NCBI] 0.000229847
CTPP1 [NCBI] 0.000228386
GLC1C [NCBI] 0.000228386
SPG12 [NCBI] 0.000228386
CTAA1 [NCBI] 0.000228386
AUTS5 [NCBI] 0.000228386
HBD [NCBI] 0.000228386
DYT7 [NCBI] 0.000228386
hereditary motor and sensory neuropathy, type iic [NCBI] 0.000228386
SCA4 [NCBI] 0.000228386
prostate cancer [NCBI] 0.000227188
EAOH [NCBI] 0.000222738
VWM [NCBI] 0.000215375
SACS [NCBI] 0.000212103
APP [NCBI] 0.000199758
vestibulopathy, familial [NCBI] 0.000195245
actinic prurigo [NCBI] 0.000195245
CCA1 [NCBI] 0.000195245
diabetes mellitus, noninsulin-dependent, 3 [NCBI] 0.000195245
macular edema, cystoid [NCBI] 0.000195245
HMN7A [NCBI] 0.000195245
ehlers-danlos syndrome, type viii [NCBI] 0.000195245
NIDDM2 [NCBI] 0.000195245
LGMD2I [NCBI] 0.000193573
BRCA2 [NCBI] 0.000189417
myoclonic epilepsy, neonatal, with suppression-burst pattern [NCBI] 0.000188406
PINK1 [NCBI] 0.000183471
spongiform encephalopathy with neuropsychiatric features [NCBI] 0.000178555
LRRK2 [NCBI] 0.00017843
SPG10 [NCBI] 0.000176129
VEGF [NCBI] 0.000175718
SNCA [NCBI] 0.000172735
FXTAS [NCBI] 0.000171536
OPMD [NCBI] 0.000170115
ECA1 [NCBI] 0.000168592
inclusion body myositis [NCBI] 0.000168592
renal failure, progressive, with hypertension [NCBI] 0.000168592
HMN1 [NCBI] 0.000168592
SPG5A [NCBI] 0.000168592
cluster headache, familial [NCBI] 0.000168592
PARK1 [NCBI] 0.000165655
CTLN2 [NCBI] 0.000165655
SMEI [NCBI] 0.000165457
SPG4 [NCBI] 0.000160566
MAPT [NCBI] 0.000158866
SCA10 [NCBI] 0.000154023
NGFB [NCBI] 0.000152497
ALD [NCBI] 0.000150553
DYT1 [NCBI] 0.000149874
PRNP [NCBI] 0.000149781
PSORS1 [NCBI] 0.000148855
amyloidosis, cerebroarterial, hereditary, iowa type [NCBI] 0.000148739
methylmalonic aciduria and homocystinuria, cblc type [NCBI] 0.000148452
SMA4 [NCBI] 0.000148452
gastroesophageal reflux [NCBI] 0.000146551
pulmonary disease, chronic obstructive [NCBI] 0.000146551
IDDM7 [NCBI] 0.000146551
LGMD2A [NCBI] 0.000146219
basal ganglia disease, adult-onset [NCBI] 0.000141288
charcot-marie-tooth disease, axonal, type 2j [NCBI] 0.000141288
NCSTN [NCBI] 0.000138783
TNF [NCBI] 0.000135219
HMN5 [NCBI] 0.000134664
ALS1 [NCBI] 0.000131388
FMF [NCBI] 0.0001294
CLN6 [NCBI] 0.000129332
POAG [NCBI] 0.0001244
PTH [NCBI] 0.00012374
citrullinemia, type ii, neonatal-onset [NCBI] 0.000119566
DYT12 [NCBI] 0.000119566
psoriatic arthritis, susceptibility to [NCBI] 0.000119566
FTL [NCBI] 0.000117234
CAPN3 [NCBI] 0.000117234
dermatitis, atopic [NCBI] 0.00011204
macular dystrophy, vitelliform, adult-onset [NCBI] 0.000111324
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2 [NCBI] 0.000111324
LORD [NCBI] 0.000110977
PEOA4 [NCBI] 0.000110977
GEPD [NCBI] 0.000110977
CLN2 [NCBI] 0.000109036
UBQLN1 [NCBI] 0.000107326
MFN2 [NCBI] 0.000105365
MPZ [NCBI] 0.000105213
PARK8 [NCBI] 0.00010493
CVS [NCBI] 0.000104573
spinocerebellar ataxia, 16q22-linked [NCBI] 0.000104205
EIF2B5 [NCBI] 0.000101593
glycogen storage disease ii [NCBI] 0.000100998
IBD5 [NCBI] 9.82616e-05
MODY3 [NCBI] 9.79519e-05
SCAR1 [NCBI] 9.79519e-05
OCD1 [NCBI] 9.79519e-05
MLH1 [NCBI] 9.77747e-05
CHAC [NCBI] 9.74445e-05
SPG3A [NCBI] 9.68216e-05
NPY [NCBI] 9.64593e-05
TTR [NCBI] 9.61578e-05
EGFR [NCBI] 9.61028e-05
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 9.48076e-05
charcot-marie-tooth disease, recessive intermediate a [NCBI] 9.41816e-05
LGMD2K [NCBI] 9.41816e-05
leber optic atrophy [NCBI] 9.35426e-05
lynch syndrome i [NCBI] 9.28293e-05
CMT4A [NCBI] 9.23856e-05
PRL [NCBI] 8.94885e-05
SACS [NCBI] 8.78413e-05
LKS [NCBI] 8.72996e-05
CYP1B1 [NCBI] 8.31288e-05
KRS [NCBI] 8.28069e-05
DRPLA [NCBI] 8.18024e-05
PWS [NCBI] 8.09554e-05
lymphoma, non-hodgkin, familial [NCBI] 7.87878e-05
ATXN8OS [NCBI] 7.81611e-05
BWS [NCBI] 7.74333e-05
DYT1 [NCBI] 7.70452e-05
PCNA [NCBI] 7.6717e-05
behcet syndrome [NCBI] 7.66374e-05
IBGC1 [NCBI] 7.56558e-05
IDDM4 [NCBI] 7.56558e-05
ASS [NCBI] 7.55358e-05
SOD1 [NCBI] 7.54303e-05
BULN2 [NCBI] 7.4364e-05
neuropathy, hereditary sensory and autonomic, adult-onset, with anosmia [NCBI] 7.4364e-05
contiguous abcd1/dxs1375e deletion syndrome [NCBI] 7.4364e-05
myotilinopathy [NCBI] 7.4364e-05
kleine-levin hibernation syndrome [NCBI] 7.4364e-05
caroli disease, isolated [NCBI] 7.4364e-05
cataract, cortical, juvenile-onset [NCBI] 7.4364e-05
myopathy, early-onset, with fatal cardiomyopathy [NCBI] 7.4364e-05
myopathy, distal, with early respiratory failure, autosomal dominant [NCBI] 7.4364e-05
HDL2 [NCBI] 7.42059e-05
LGMD2F [NCBI] 7.42059e-05
HDL1 [NCBI] 7.42059e-05
DFNB8 [NCBI] 7.42059e-05
minicore myopathy with external ophthalmoplegia [NCBI] 7.42059e-05
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant [NCBI] 7.42059e-05
A2M [NCBI] 7.36136e-05
PRX [NCBI] 7.30635e-05
AVP [NCBI] 7.22483e-05
HNF1A [NCBI] 7.1978e-05
RSMD1 [NCBI] 7.13405e-05
obesity [NCBI] 7.01769e-05
ELAC2 [NCBI] 6.96981e-05
CRH [NCBI] 6.8297e-05
EA2 [NCBI] 6.80668e-05
FTLDU [NCBI] 6.80668e-05
SCA5 [NCBI] 6.73123e-05
MPD1 [NCBI] 6.73123e-05
FHL2 [NCBI] 6.73123e-05
OPTN [NCBI] 6.70454e-05
PPT1 [NCBI] 6.62933e-05
SGCE [NCBI] 6.54332e-05
ARPKD [NCBI] 6.53924e-05
GEFS+ [NCBI] 6.5016e-05
GAA [NCBI] 6.48485e-05
MM [NCBI] 6.36607e-05
krabbe disease [NCBI] 6.35712e-05
ACHE [NCBI] 6.29434e-05
TOR1B [NCBI] 6.22234e-05
SLC25A13 [NCBI] 6.20142e-05
SMA3 [NCBI] 6.17604e-05
prostate cancer/brain cancer susceptibility [NCBI] 6.15809e-05
PGL4 [NCBI] 6.15809e-05
APTX [NCBI] 6.0769e-05
CCK [NCBI] 5.95813e-05
GLC3A [NCBI] 5.94876e-05
ETM1 [NCBI] 5.94876e-05
COMT [NCBI] 5.93519e-05
CACNA1A [NCBI] 5.91596e-05
FKRP [NCBI] 5.87568e-05
glaucoma-related pigment dispersion syndrome [NCBI] 5.80225e-05
alopecia areata 1 [NCBI] 5.80225e-05
SCN1A [NCBI] 5.78151e-05
FXN [NCBI] 5.75035e-05
SETX [NCBI] 5.72225e-05
osteogenic sarcoma [NCBI] 5.66933e-05
PLSJ [NCBI] 5.66933e-05
SPG11 [NCBI] 5.66933e-05
CMT4B2 [NCBI] 5.66933e-05
HHF6 [NCBI] 5.66933e-05
CMT2D [NCBI] 5.66933e-05
MFS [NCBI] 5.62105e-05
CLN1 [NCBI] 5.45987e-05
DRD [NCBI] 5.45987e-05
FRDA [NCBI] 5.39634e-05
CST3 [NCBI] 5.36279e-05
HGF [NCBI] 5.32532e-05
NIDDM [NCBI] 5.30984e-05
NF2 [NCBI] 5.30805e-05
GCH1 [NCBI] 5.28783e-05
LGMD2E [NCBI] 5.2447e-05
alzheimer disease 4 [NCBI] 5.2447e-05
CLN8 [NCBI] 5.2447e-05
myopathy, myofibrillar, desmin-related [NCBI] 5.23571e-05
BIRC1 [NCBI] 5.17586e-05
ETFDH [NCBI] 5.08947e-05
glutathione s-transferase, omega-1 [NCBI] 5.08947e-05
TH [NCBI] 5.07239e-05
alsin [NCBI] 5.04162e-05
ATXN2 [NCBI] 5.04162e-05
gaucher disease, type iii [NCBI] 5.02348e-05
PDB [NCBI] 5.02348e-05
VMD [NCBI] 5.02072e-05
DM2 [NCBI] 4.87695e-05
HNPCC2 [NCBI] 4.87047e-05
cirrhosis, familial [NCBI] 4.87047e-05
SCA14 [NCBI] 4.87047e-05
CMT2A2 [NCBI] 4.87047e-05
GDAP1 [NCBI] 4.78199e-05
COCH [NCBI] 4.78199e-05
MYBPC3 [NCBI] 4.78199e-05
ARSA [NCBI] 4.77878e-05
PKD1 [NCBI] 4.75561e-05
CJD [NCBI] 4.70941e-05
SMN2 [NCBI] 4.70929e-05
ATP7B [NCBI] 4.70929e-05
NFRCD [NCBI] 4.70855e-05
RP31 [NCBI] 4.70855e-05
adie pupil [NCBI] 4.70855e-05
periodontitis, chronic [NCBI] 4.70855e-05
CMH8 [NCBI] 4.70855e-05
epilepsy, childhood absence, 2 [NCBI] 4.70855e-05
DFNA23 [NCBI] 4.70855e-05
SCAR8 [NCBI] 4.70855e-05
kifafa seizure disorder [NCBI] 4.70855e-05
MODY6 [NCBI] 4.70855e-05
DSMA4 [NCBI] 4.70855e-05
creases, infra-auricular cutaneous, with tall stature and advanced bone age [NCBI] 4.70855e-05
epilepsy with bilateral occipital calcifications [NCBI] 4.70855e-05
myocardial infarction, susceptibility to, 1 [NCBI] 4.70855e-05
SGCA [NCBI] 4.66575e-05
FHM1 [NCBI] 4.63096e-05
ABCA4 [NCBI] 4.59946e-05
MTR [NCBI] 4.56741e-05
osteoporosis, juvenile [NCBI] 4.53693e-05
renal cysts and diabetes syndrome [NCBI] 4.53693e-05
NR4A2 [NCBI] 4.3587e-05
SPR [NCBI] 4.3587e-05
hypertrophic neuropathy of dejerine-sottas [NCBI] 4.34538e-05
BFSP1 [NCBI] 4.22991e-05
CLN6 [NCBI] 4.22991e-05
EIF2B2 [NCBI] 4.22991e-05
NF2 [NCBI] 4.22242e-05
DRD3 [NCBI] 4.1815e-05
polycystic kidneys [NCBI] 4.04933e-05
breast cancer [NCBI] 4.03355e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive [NCBI] 3.96504e-05
SBF2 [NCBI] 3.96298e-05
KIF5A [NCBI] 3.96298e-05
LGMD2C [NCBI] 3.95234e-05
CDSN [NCBI] 3.94692e-05
IDE [NCBI] 3.91863e-05
IGAN1 [NCBI] 3.8201e-05
CDAN2 [NCBI] 3.8201e-05
CDH1 [NCBI] 3.8076e-05
GALC [NCBI] 3.80734e-05
HNF4A [NCBI] 3.77144e-05
CLN2 [NCBI] 3.74676e-05
SUMO4 [NCBI] 3.74676e-05
SORL1 [NCBI] 3.74676e-05
VPS13A [NCBI] 3.74676e-05
BHC [NCBI] 3.71708e-05
tibial muscular dystrophy, tardive [NCBI] 3.71708e-05
glutaric acidemia i [NCBI] 3.71708e-05
JH [NCBI] 3.71708e-05
LGMD2B [NCBI] 3.71708e-05
FEB8 [NCBI] 3.70979e-05
IAHSP [NCBI] 3.70979e-05
macular dystrophy, concentric annular [NCBI] 3.70979e-05
SCA11 [NCBI] 3.70979e-05
charcot-marie-tooth disease, axonal, type 2i [NCBI] 3.70979e-05
ALS8 [NCBI] 3.70979e-05
fundus dystrophy, pseudoinflammatory, recessive form [NCBI] 3.70979e-05
chondrosarcoma [NCBI] 3.70979e-05
MODY8 [NCBI] 3.70979e-05
charcot-marie-tooth disease, axonal, type 2f [NCBI] 3.70979e-05
glomerulocystic kidney disease with hyperuricemia and isosthenuria [NCBI] 3.70979e-05
CMTX5 [NCBI] 3.70979e-05
LBSL [NCBI] 3.70979e-05
bile acid synthesis defect, congenital, 4 [NCBI] 3.70979e-05
camera-marugo-cohen syndrome [NCBI] 3.70979e-05
keloids [NCBI] 3.70979e-05
MODY4 [NCBI] 3.70979e-05
glycogen storage disease 0, liver [NCBI] 3.70979e-05
leprosy, susceptibility to, 4 [NCBI] 3.70979e-05
mitochondrial complex iv deficiency [NCBI] 3.65677e-05
PGL1 [NCBI] 3.65677e-05
TMPRSS3 [NCBI] 3.56505e-05
autism [NCBI] 3.56022e-05
NPC1 [NCBI] 3.55607e-05
dystrophia myotonica 1 [NCBI] 3.50582e-05
MSH6 [NCBI] 3.50342e-05
exostoses, multiple, type ii [NCBI] 3.48971e-05
NBIA1 [NCBI] 3.48971e-05
IL1A [NCBI] 3.44898e-05
MTRNR1 [NCBI] 3.44898e-05
FCAS [NCBI] 3.38555e-05
CADASIL [NCBI] 3.38555e-05
CLL [NCBI] 3.38555e-05
AT [NCBI] 3.38319e-05
anemia, sideroblastic, x-linked [NCBI] 3.29608e-05
aneurysm, intracranial berry, 1 [NCBI] 3.29576e-05
SLOS [NCBI] 3.26976e-05
OPA1 [NCBI] 3.25816e-05
RET [NCBI] 3.25047e-05
MDM2 [NCBI] 3.20182e-05
fragile x mental retardation syndrome [NCBI] 3.15811e-05
NAGS [NCBI] 3.14814e-05
flj10986 [NCBI] 3.11094e-05
C10ORF6 [NCBI] 3.11094e-05
ASAH2C [NCBI] 3.11094e-05
ORMDL3 [NCBI] 3.11094e-05
glycogen storage disease iv [NCBI] 3.0866e-05
BJS [NCBI] 3.07857e-05
hereditary motor and sensory neuropathy vi [NCBI] 3.07857e-05
FHL4 [NCBI] 3.07857e-05
SPG8 [NCBI] 3.07857e-05
coronary heart disease, susceptibility to, 5 [NCBI] 3.07857e-05
SCA13 [NCBI] 3.07857e-05
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive [NCBI] 3.07857e-05
cardiomyopathy, dilated, autosomal recessive [NCBI] 3.07857e-05
HHF3 [NCBI] 3.07857e-05
FSGS2 [NCBI] 3.07857e-05
CELIAC4 [NCBI] 3.07857e-05
sarcoidosis, early-onset [NCBI] 3.07857e-05
familial mediterranean fever, autosomal dominant [NCBI] 3.07857e-05
SCA27 [NCBI] 3.07857e-05
CLN7 [NCBI] 3.07857e-05
cervical cancer [NCBI] 3.07857e-05
cataract, autosomal dominant, multiple types 1 [NCBI] 3.07857e-05
SPG7 [NCBI] 3.07857e-05
NLRP3 [NCBI] 3.03758e-05
TTPA [NCBI] 3.03758e-05
BFSP2 [NCBI] 3.03758e-05
GRN [NCBI] 3.02889e-05
myoclonic epilepsy of unverricht and lundborg [NCBI] 3.01829e-05
PON1 [NCBI] 2.99628e-05
AFP [NCBI] 2.96215e-05
FA [NCBI] 2.92779e-05
HIDS [NCBI] 2.90685e-05
pancreatic carcinoma [NCBI] 2.90685e-05
SMN1 [NCBI] 2.89219e-05
POLG [NCBI] 2.87347e-05
GARS [NCBI] 2.84473e-05
MCDR1 [NCBI] 2.82751e-05
CHS [NCBI] 2.79128e-05
NOTCH3 [NCBI] 2.75958e-05
CRYGD [NCBI] 2.75958e-05
POMT1 [NCBI] 2.68055e-05
BMPR2 [NCBI] 2.68055e-05
ME2 [NCBI] 2.68055e-05
PKHD1 [NCBI] 2.68055e-05
PLAU [NCBI] 2.68055e-05
SDHB [NCBI] 2.68055e-05
oncogene dj1 [NCBI] 2.68055e-05
LRP1 [NCBI] 2.65686e-05
CCZS [NCBI] 2.6219e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii [NCBI] 2.6219e-05
aromatic l-amino acid decarboxylase deficiency [NCBI] 2.6219e-05
niemann-pick disease, type c2 [NCBI] 2.6219e-05
FCDT [NCBI] 2.6219e-05
IDDM10 [NCBI] 2.6219e-05
n-acetylglutamate synthase deficiency [NCBI] 2.6219e-05
IDDM12 [NCBI] 2.6219e-05
anderson disease [NCBI] 2.6219e-05
DFNA10 [NCBI] 2.6219e-05
DFNA13 [NCBI] 2.6219e-05
NN [NCBI] 2.6219e-05
PGL3 [NCBI] 2.6219e-05
POF2A [NCBI] 2.6219e-05
CMD1D [NCBI] 2.6219e-05
paroxysmal extreme pain disorder [NCBI] 2.6219e-05
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency [NCBI] 2.6219e-05
epidermolysis bullosa pruriginosa [NCBI] 2.6219e-05
ovarian cancer, epithelial [NCBI] 2.6219e-05
PC2 [NCBI] 2.6219e-05
myopathy, centronuclear, autosomal recessive [NCBI] 2.6219e-05
CTPP3 [NCBI] 2.6219e-05
asthma-related traits, susceptibility to, 5 [NCBI] 2.6219e-05
seizures, benign familial neonatal-infantile [NCBI] 2.6219e-05
3-@methylcrotonyl-coa carboxylase 2 deficiency [NCBI] 2.6219e-05
cystinosis, late-onset juvenile or adolescent nephropathic type [NCBI] 2.6219e-05
melanoma-pancreatic cancer syndrome [NCBI] 2.6219e-05
PANK2 [NCBI] 2.60684e-05
ATP1A2 [NCBI] 2.60684e-05
BEST1 [NCBI] 2.60684e-05
APL [NCBI] 2.58335e-05
SCA17 [NCBI] 2.58335e-05
mismatch repair cancer syndrome [NCBI] 2.58335e-05
RNASEL [NCBI] 2.53781e-05
FFI [NCBI] 2.52083e-05
OTC [NCBI] 2.5142e-05
MYH7 [NCBI] 2.5142e-05
WAS [NCBI] 2.5019e-05
JPS [NCBI] 2.49387e-05
SPG7 [NCBI] 2.47292e-05
MPO [NCBI] 2.44712e-05
PPH1 [NCBI] 2.43723e-05
megaloblastic anemia 1 [NCBI] 2.43723e-05
ADRB3 [NCBI] 2.41172e-05
AS [NCBI] 2.38627e-05
HFE [NCBI] 2.38027e-05
MTND4 [NCBI] 2.35009e-05
NOS3 [NCBI] 2.35009e-05
PSNP1 [NCBI] 2.30022e-05
USH2A [NCBI] 2.30022e-05
SPG11 [NCBI] 2.28937e-05
TBL1Y [NCBI] 2.28937e-05
TOR2A [NCBI] 2.28937e-05
FGF11 [NCBI] 2.28937e-05
PCDH9 [NCBI] 2.28937e-05
breast cancer cell 2 [NCBI] 2.28937e-05
ectodermal dysplasia, hypohidrotic, with immune deficiency [NCBI] 2.26804e-05
FANCD1 [NCBI] 2.26804e-05
DFNB10 [NCBI] 2.26804e-05
charcot-marie-tooth disease, axonal, type 2b1 [NCBI] 2.26804e-05
CINCA [NCBI] 2.26804e-05
FPLD3 [NCBI] 2.26804e-05
adenylosuccinase deficiency [NCBI] 2.26804e-05
alternating hemiplegia of childhood [NCBI] 2.26804e-05
stickler syndrome, type i, nonsyndromic ocular [NCBI] 2.26804e-05
SPG13 [NCBI] 2.26804e-05
cataract, lamellar [NCBI] 2.26804e-05
CGL1 [NCBI] 2.26804e-05
leukodystrophy, adult-onset, autosomal dominant [NCBI] 2.26804e-05
CMRD [NCBI] 2.26804e-05
DFNA20 [NCBI] 2.26804e-05
HLA-DQB1 [NCBI] 2.24672e-05
alopecia, androgenetic [NCBI] 2.23319e-05
SDHD [NCBI] 2.19698e-05
RPE65 [NCBI] 2.19698e-05
CRMO [NCBI] 2.17152e-05
HOKPP [NCBI] 2.17152e-05
HNF1B [NCBI] 2.1495e-05
CFTR [NCBI] 2.14081e-05
ABCD1 [NCBI] 2.13501e-05
MBP [NCBI] 2.09465e-05
MC4R [NCBI] 2.09146e-05
SCZD [NCBI] 2.0681e-05
HSCR1 [NCBI] 2.05202e-05
PNKD1 [NCBI] 2.05042e-05
CCA2 [NCBI] 1.98212e-05
pancreatic cancer, susceptibility to, 1 [NCBI] 1.98212e-05
SPMM [NCBI] 1.98212e-05
hypotrichosis simplex of scalp [NCBI] 1.98212e-05
CPVT [NCBI] 1.98212e-05
IDDM5 [NCBI] 1.98212e-05
GBS [NCBI] 1.98212e-05
sturge-weber syndrome [NCBI] 1.98212e-05
pierson syndrome [NCBI] 1.98212e-05
CZP3 [NCBI] 1.98212e-05
FSGS1 [NCBI] 1.98212e-05
pneumothorax, primary spontaneous [NCBI] 1.98212e-05
ATP13A2 [NCBI] 1.98127e-05
SCO1 [NCBI] 1.98127e-05
HS1BP3 [NCBI] 1.98127e-05
TTBK2 [NCBI] 1.98127e-05
NDUFS6 [NCBI] 1.98127e-05
PPEF1 [NCBI] 1.98127e-05
PLEKHG5 [NCBI] 1.98127e-05
KCNRG [NCBI] 1.98127e-05
VAMP3 [NCBI] 1.98127e-05
USP24 [NCBI] 1.98127e-05
ASAH2 [NCBI] 1.98127e-05
SMA1 [NCBI] 1.97952e-05
MTTL1 [NCBI] 1.94927e-05
PRSS1 [NCBI] 1.94019e-05
SLC25A4 [NCBI] 1.94019e-05
SMA2 [NCBI] 1.9363e-05
HNFJ [NCBI] 1.9363e-05
ALMS [NCBI] 1.9363e-05
BDNF [NCBI] 1.89081e-05
NPC1 [NCBI] 1.86719e-05
CSTB [NCBI] 1.86719e-05
PRODH [NCBI] 1.86719e-05
DFNB1 [NCBI] 1.8286e-05
PCD [NCBI] 1.81681e-05
RTT [NCBI] 1.80038e-05
MAOB [NCBI] 1.79916e-05
CTNNA3 [NCBI] 1.7823e-05
fe65-like 2 [NCBI] 1.7823e-05
SH2D2A [NCBI] 1.7823e-05
C1QTNF5 [NCBI] 1.7823e-05
PLEKHG4 [NCBI] 1.7823e-05
POLG2 [NCBI] 1.7823e-05
APBB2 [NCBI] 1.7823e-05
CYP46A1 [NCBI] 1.7823e-05
ETFB [NCBI] 1.7823e-05
RRAD [NCBI] 1.7823e-05
GAPDHS [NCBI] 1.7823e-05
COX15 [NCBI] 1.7823e-05
TG [NCBI] 1.76611e-05
CHAT [NCBI] 1.74967e-05
EPPK [NCBI] 1.74448e-05
opitz syndrome [NCBI] 1.74448e-05
rheumatoid arthritis, systemic juvenile [NCBI] 1.74448e-05
kuru, susceptibility to [NCBI] 1.74448e-05
ODG2 [NCBI] 1.74448e-05
epilepsy, nocturnal frontal lobe, type 1 [NCBI] 1.74448e-05
IBMPFD [NCBI] 1.74448e-05
MDC1C [NCBI] 1.74448e-05
hyperferritinemia-cataract syndrome [NCBI] 1.74448e-05
vitiligo [NCBI] 1.74448e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3 [NCBI] 1.74448e-05
BPP [NCBI] 1.74448e-05
PARK4 [NCBI] 1.74448e-05
CMT4B1 [NCBI] 1.74448e-05
HEXA [NCBI] 1.73663e-05
CD [NCBI] 1.73141e-05
myoclonic epilepsy of lafora [NCBI] 1.72684e-05
TYMS [NCBI] 1.67374e-05
LPL [NCBI] 1.66385e-05
BBS [NCBI] 1.65285e-05
apc gene [NCBI] 1.64761e-05
FOXE3 [NCBI] 1.63518e-05
SLC25A19 [NCBI] 1.63518e-05
NDUFV2 [NCBI] 1.63518e-05
FGF13 [NCBI] 1.63518e-05
TFCP2 [NCBI] 1.63518e-05
RABGAP1L [NCBI] 1.63518e-05
BCAP31 [NCBI] 1.63518e-05
ETFA [NCBI] 1.63518e-05
SIM1 [NCBI] 1.63518e-05
CRYGS [NCBI] 1.63518e-05
KCNC3 [NCBI] 1.63518e-05
PACRG [NCBI] 1.63518e-05
C1S [NCBI] 1.63518e-05
ATXN10 [NCBI] 1.63518e-05
MCHR2 [NCBI] 1.63518e-05
IRAK3 [NCBI] 1.63518e-05
LEPR [NCBI] 1.62739e-05
MS [NCBI] 1.59436e-05
NOD2 [NCBI] 1.59256e-05
ACE [NCBI] 1.57877e-05
STK11 [NCBI] 1.56636e-05
HMN2A [NCBI] 1.54294e-05
alpha-methylacetoacetic aciduria [NCBI] 1.54294e-05
VLDLRCH [NCBI] 1.54294e-05
fundus albipunctatus [NCBI] 1.54294e-05
hyperlipidemia, combined, 1 [NCBI] 1.54294e-05
RP12 [NCBI] 1.54294e-05
DFNA9 [NCBI] 1.54294e-05
FTD3 [NCBI] 1.54294e-05
HFE3 [NCBI] 1.54294e-05
immunoosseous dysplasia, schimke type [NCBI] 1.54294e-05
CMH4 [NCBI] 1.54294e-05
ADHR [NCBI] 1.54294e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative [NCBI] 1.54294e-05
MODY2 [NCBI] 1.54294e-05
hydrops-ectopic calcification-moth-eaten skeletal dysplasia [NCBI] 1.54294e-05
AML [NCBI] 1.54294e-05
SCA12 [NCBI] 1.54294e-05
NRCLP1 [NCBI] 1.53946e-05
CMM [NCBI] 1.53658e-05
GDNF [NCBI] 1.51968e-05
MFRP [NCBI] 1.51858e-05
MPV17 [NCBI] 1.51858e-05
EIF2B4 [NCBI] 1.51858e-05
PCDH8 [NCBI] 1.51858e-05
MYL3 [NCBI] 1.51858e-05
COPA [NCBI] 1.51858e-05
CSEN [NCBI] 1.51858e-05
NPHP3 [NCBI] 1.51858e-05
TOPORS [NCBI] 1.51858e-05
NTF5 [NCBI] 1.51858e-05
MLH3 [NCBI] 1.51858e-05
MTTF [NCBI] 1.51858e-05
NIPA1 [NCBI] 1.51858e-05
GLA [NCBI] 1.4919e-05
GJB2 [NCBI] 1.47878e-05
FPLD2 [NCBI] 1.45311e-05
exostoses, multiple, type i [NCBI] 1.45311e-05
FTO [NCBI] 1.42215e-05
SYNE1 [NCBI] 1.42215e-05
NHLH1 [NCBI] 1.42215e-05
TTID [NCBI] 1.42215e-05
HSF4 [NCBI] 1.42215e-05
NDUFS8 [NCBI] 1.42215e-05
PRPS2 [NCBI] 1.42215e-05
NHLRC1 [NCBI] 1.42215e-05
HLA-DPB1 [NCBI] 1.42215e-05
CRYM [NCBI] 1.42215e-05
TCF7L2 [NCBI] 1.40113e-05
G6PD [NCBI] 1.37536e-05
periodic fever, familial, autosomal dominant [NCBI] 1.37122e-05
gastric cancer [NCBI] 1.37122e-05
schwannomatosis [NCBI] 1.36943e-05
trifunctional protein deficiency [NCBI] 1.36943e-05
PKD3 [NCBI] 1.36943e-05
HFE4 [NCBI] 1.36943e-05
lymphedema, hereditary, i [NCBI] 1.36943e-05
monosomy 7 of bone marrow [NCBI] 1.36943e-05
alzheimer disease, susceptibility to, mitochondrial [NCBI] 1.36943e-05
SPG17 [NCBI] 1.36943e-05
NYS1 [NCBI] 1.36943e-05
CMT4C [NCBI] 1.36943e-05
SPP1 [NCBI] 1.36278e-05
HCRT [NCBI] 1.35894e-05
PRF1 [NCBI] 1.35894e-05
CCHCR1 [NCBI] 1.34006e-05
ISL1 [NCBI] 1.34006e-05
CTF1 [NCBI] 1.34006e-05
AGRP [NCBI] 1.34006e-05
SEPN1 [NCBI] 1.34006e-05
PRPF31 [NCBI] 1.34006e-05
CBLB [NCBI] 1.34006e-05
ERRFI1 [NCBI] 1.34006e-05
FSCN2 [NCBI] 1.34006e-05
SLC22A4 [NCBI] 1.34006e-05
IP [NCBI] 1.33641e-05
IDDM [NCBI] 1.33516e-05
GJB1 [NCBI] 1.31479e-05
CCND1 [NCBI] 1.27021e-05
TK2 [NCBI] 1.2687e-05
FGF20 [NCBI] 1.2687e-05
FGF14 [NCBI] 1.2687e-05
MIRN16-1 [NCBI] 1.2687e-05
HTR2C [NCBI] 1.2687e-05
SIPA1 [NCBI] 1.2687e-05
PPP2R2B [NCBI] 1.2687e-05
ABCA2 [NCBI] 1.2687e-05
hemojuvelin [NCBI] 1.2687e-05
CASQ2 [NCBI] 1.2687e-05
BSCL2 [NCBI] 1.2687e-05
CMH [NCBI] 1.24479e-05
MSH2 [NCBI] 1.24323e-05
fabry disease [NCBI] 1.22437e-05
RP11 [NCBI] 1.2183e-05
SPG6 [NCBI] 1.2183e-05
myeloma, multiple [NCBI] 1.2183e-05
CDL1 [NCBI] 1.2183e-05
SCN1B [NCBI] 1.20565e-05
SCO2 [NCBI] 1.20565e-05
HTRA1 [NCBI] 1.20565e-05
AIP [NCBI] 1.20565e-05
ICSBP1 [NCBI] 1.20565e-05
EYA4 [NCBI] 1.20565e-05
CDKL5 [NCBI] 1.20565e-05
GBE1 [NCBI] 1.20565e-05
GNRH1 [NCBI] 1.20363e-05
LAM [NCBI] 1.17152e-05
GAPDH [NCBI] 1.16373e-05
migraine with or without aura, susceptibility to, 1 [NCBI] 1.15658e-05
mitochondrial complex i deficiency [NCBI] 1.14959e-05
NEUROD1 [NCBI] 1.14925e-05
SLC17A5 [NCBI] 1.14925e-05
GATA2 [NCBI] 1.14925e-05
LIM2 [NCBI] 1.14925e-05
FSHMD1A [NCBI] 1.147e-05
PITX3 [NCBI] 1.09829e-05
DGUOK [NCBI] 1.09829e-05
FLCN [NCBI] 1.09829e-05
ZNF9 [NCBI] 1.09829e-05
ADHD [NCBI] 1.09591e-05
RB1 [NCBI] 1.08911e-05
SFD [NCBI] 1.08547e-05
LGMD2D [NCBI] 1.08547e-05
gaucher disease, type ii [NCBI] 1.08547e-05
MTC [NCBI] 1.08547e-05
LGMD2H [NCBI] 1.08547e-05
CLN5 [NCBI] 1.08547e-05
SNDI [NCBI] 1.08547e-05
CYLD [NCBI] 1.08547e-05
CMT2B [NCBI] 1.08547e-05
TNFRSF11B [NCBI] 1.08216e-05
APC [NCBI] 1.05209e-05
SIX1 [NCBI] 1.05185e-05
NPC2 [NCBI] 1.05185e-05
CRYGC [NCBI] 1.05185e-05
PRKAG2 [NCBI] 1.05185e-05
PRKCZ [NCBI] 1.05185e-05
DBA [NCBI] 1.03778e-05
POMC [NCBI] 1.01863e-05
TRAPPC2 [NCBI] 1.00923e-05
RAI1 [NCBI] 1.00923e-05
HCRTR2 [NCBI] 1.00923e-05
MSR1 [NCBI] 1.00923e-05
OLR1 [NCBI] 1.00923e-05
HLCS [NCBI] 1.00923e-05
SDHC [NCBI] 1.00923e-05
HGD [NCBI] 1.00923e-05
CCR5 [NCBI] 1.00873e-05
GFAP [NCBI] 9.96974e-06
IL10 [NCBI] 9.95279e-06
DVL1 [NCBI] 9.69899e-06
TNNI3 [NCBI] 9.69899e-06
3-@hydroxy-3-methylglutaryl-coa lyase deficiency [NCBI] 9.69899e-06
HSPD1 [NCBI] 9.69899e-06
SMARCB1 [NCBI] 9.69899e-06
NR0B2 [NCBI] 9.69064e-06
ARH [NCBI] 9.67876e-06
wolff-parkinson-white syndrome [NCBI] 9.67876e-06
pick disease of brain [NCBI] 9.67876e-06
CMT2A1 [NCBI] 9.67876e-06
synovitis, granulomatous, with uveitis and cranial neuropathies [NCBI] 9.67876e-06
autoimmune disease [NCBI] 9.67876e-06
ALS2 [NCBI] 9.67876e-06
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1 [NCBI] 9.67876e-06
aHUS [NCBI] 9.59315e-06
SIX5 [NCBI] 9.33402e-06
ATRN [NCBI] 9.33402e-06
TNFRSF11A [NCBI] 9.33402e-06
PDCD1 [NCBI] 9.33402e-06
CTNS [NCBI] 9.33402e-06
CRB1 [NCBI] 9.33402e-06
SGSH [NCBI] 9.33402e-06
CRC [NCBI] 8.99899e-06
LRAT [NCBI] 8.9939e-06
RAPSN [NCBI] 8.9939e-06
CPS1 [NCBI] 8.9939e-06
WT1 [NCBI] 8.96307e-06
AR [NCBI] 8.7803e-06
APOM [NCBI] 8.67569e-06
GABRG2 [NCBI] 8.67569e-06
ATXN7 [NCBI] 8.67569e-06
USH2A [NCBI] 8.67569e-06
MODY1 [NCBI] 8.63167e-06
mitochondrial dna depletion syndrome, hepatocerebral form [NCBI] 8.63167e-06
AGS1 [NCBI] 8.63167e-06
BHD [NCBI] 8.63167e-06
EA1 [NCBI] 8.63167e-06
cerebrotendinous xanthomatosis [NCBI] 8.63167e-06
coenzyme q10 deficiency [NCBI] 8.63167e-06
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis [NCBI] 8.63167e-06
PTHLH [NCBI] 8.60577e-06
VHL [NCBI] 8.56975e-06
MTHFR [NCBI] 8.50178e-06
TP53 [NCBI] 8.43184e-06
MAPK8IP1 [NCBI] 8.37696e-06
UCHL1 [NCBI] 8.37696e-06
ACADVL [NCBI] 8.37696e-06
GLUD1 [NCBI] 8.37696e-06
SQSTM1 [NCBI] 8.37696e-06
GLDC [NCBI] 8.37696e-06
KLK3 [NCBI] 8.23614e-06
IBD1 [NCBI] 8.18271e-06
APS1 [NCBI] 8.14267e-06
FGF9 [NCBI] 8.09564e-06
PRKCG [NCBI] 8.09564e-06
NEU1 [NCBI] 7.83001e-06
GALK1 [NCBI] 7.83001e-06
PHOX2B [NCBI] 7.83001e-06
DHCR7 [NCBI] 7.83001e-06
CACNA1S [NCBI] 7.83001e-06
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase [NCBI] 7.83001e-06
phenylketonuria ii [NCBI] 7.83001e-06
esophageal cancer [NCBI] 7.69497e-06
ADLTE [NCBI] 7.69497e-06
potocki-shaffer syndrome [NCBI] 7.69497e-06
muckle-wells syndrome [NCBI] 7.69497e-06
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1 [NCBI] 7.69497e-06
CFTD [NCBI] 7.69497e-06
holocarboxylase synthetase deficiency [NCBI] 7.69497e-06
XK [NCBI] 7.57855e-06
HR [NCBI] 7.57855e-06
CHRNA1 [NCBI] 7.57855e-06
DSP [NCBI] 7.57855e-06
CLN3 [NCBI] 7.57855e-06
CPT2 [NCBI] 7.57855e-06
MYH6 [NCBI] 7.57855e-06
COL2A1 [NCBI] 7.57812e-06
PPARA [NCBI] 7.46824e-06
GCK [NCBI] 7.38882e-06
DBH [NCBI] 7.33999e-06
FOXC2 [NCBI] 7.33999e-06
GJB3 [NCBI] 7.1132e-06
CAPN10 [NCBI] 7.1132e-06
WFS1 [NCBI] 7.1132e-06
MAS [NCBI] 7.08501e-06
RTS [NCBI] 6.99052e-06
LI1 [NCBI] 6.99052e-06
BCHE [NCBI] 6.92252e-06
TGFBI [NCBI] 6.89719e-06
EMD [NCBI] 6.89719e-06
CRYAA [NCBI] 6.89719e-06
MTND3 [NCBI] 6.89719e-06
SHBG [NCBI] 6.88595e-06
HSAN2 [NCBI] 6.85391e-06
GCE [NCBI] 6.85391e-06
pseudoxanthoma elasticum, forme fruste [NCBI] 6.85391e-06
VED [NCBI] 6.85391e-06
MIP [NCBI] 6.69111e-06
MTCO3 [NCBI] 6.69111e-06
HLA-DRB1 [NCBI] 6.69111e-06
LRP5 [NCBI] 6.69111e-06
EGR2 [NCBI] 6.69111e-06
SLC12A3 [NCBI] 6.69111e-06
LMNA [NCBI] 6.68229e-06
HTR2A [NCBI] 6.49419e-06
PMS2 [NCBI] 6.49419e-06
APOB [NCBI] 6.44802e-06
GJA5 [NCBI] 6.30575e-06
CRYAB [NCBI] 6.30575e-06
LRP8 [NCBI] 6.30575e-06
MVK [NCBI] 6.30575e-06
SLC17A7 [NCBI] 6.12519e-06
GJA8 [NCBI] 6.12519e-06
TIMP3 [NCBI] 6.12519e-06
KL [NCBI] 6.12519e-06
TNNT2 [NCBI] 6.12519e-06
MKKS [NCBI] 6.09651e-06
PHA [NCBI] 6.09651e-06
diabetes-deafness syndrome, maternally transmitted [NCBI] 6.09651e-06
alkaptonuria [NCBI] 6.09651e-06
acromegaly [NCBI] 6.09651e-06
SPG2 [NCBI] 6.09651e-06
crigler-najjar syndrome [NCBI] 6.09651e-06
wilson disease [NCBI] 6.07241e-06
IPF1 [NCBI] 5.95196e-06
FABP2 [NCBI] 5.95196e-06
KRT14 [NCBI] 5.95196e-06
TTN [NCBI] 5.78557e-06
HSPB1 [NCBI] 5.78557e-06
NOS2A [NCBI] 5.78557e-06
diabetes mellitus, insulin-dependent, 2 [NCBI] 5.653e-06
IL1B [NCBI] 5.62558e-06
COL4A5 [NCBI] 5.62558e-06
RBP4 [NCBI] 5.62558e-06
ATXN1 [NCBI] 5.62558e-06
IRS2 [NCBI] 5.62558e-06
GCDH [NCBI] 5.62558e-06
CGD [NCBI] 5.58441e-06
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 5.58441e-06
LS [NCBI] 5.58441e-06
ABCC8 [NCBI] 5.54373e-06
PPARG [NCBI] 5.47526e-06
MEFV [NCBI] 5.47159e-06
SMAD4 [NCBI] 5.47159e-06
FBS [NCBI] 5.41291e-06
FHM2 [NCBI] 5.41291e-06
IL12B [NCBI] 5.32323e-06
DYSF [NCBI] 5.32323e-06
ATM [NCBI] 5.27484e-06
CFH [NCBI] 5.27484e-06
SAA1 [NCBI] 5.18019e-06
IKBKG [NCBI] 5.04214e-06
CDK6 [NCBI] 5.04214e-06
ICAM1 [NCBI] 4.90882e-06
GHRL [NCBI] 4.90882e-06
OA1 [NCBI] 4.90882e-06
CDKN2A [NCBI] 4.83461e-06
HNA [NCBI] 4.7949e-06
acyl-coa dehydrogenase, very long-chain, deficiency of [NCBI] 4.7949e-06
IBM2 [NCBI] 4.7949e-06
bethlem myopathy [NCBI] 4.7949e-06
PHEX [NCBI] 4.77996e-06
ABCC6 [NCBI] 4.77996e-06
BCL6 [NCBI] 4.77996e-06
ACADS [NCBI] 4.65534e-06
LTA [NCBI] 4.65534e-06
RS1 [NCBI] 4.53474e-06
MICA [NCBI] 4.53474e-06
CHEK2 [NCBI] 4.53474e-06
TPI1 [NCBI] 4.53474e-06
ADRB2 [NCBI] 4.53474e-06
NR0B1 [NCBI] 4.41795e-06
TF [NCBI] 4.38397e-06
CTGF [NCBI] 4.35744e-06
DES [NCBI] 4.30479e-06
UMOD [NCBI] 4.30479e-06
LIF [NCBI] 4.30479e-06
autonomic control, congenital failure of [NCBI] 4.23556e-06
HEPOD [NCBI] 4.23556e-06
ORW2 [NCBI] 4.23556e-06
CTLA4 [NCBI] 4.08867e-06
TBP [NCBI] 4.05591e-06
SCN4A [NCBI] 3.98541e-06
AMACR [NCBI] 3.98541e-06
MTCYB [NCBI] 3.98541e-06
SDS [NCBI] 3.98375e-06
temporal arteritis [NCBI] 3.95844e-06
BCNS [NCBI] 3.91998e-06
CYP17A1 [NCBI] 3.88515e-06
USF1 [NCBI] 3.88515e-06
CGL2 [NCBI] 3.72901e-06
MNGIE [NCBI] 3.72901e-06
CCAL2 [NCBI] 3.72901e-06
UCMD [NCBI] 3.72901e-06
RELN [NCBI] 3.69314e-06
ABCA1 [NCBI] 3.60115e-06
DMPK [NCBI] 3.60115e-06
TNFRSF6 [NCBI] 3.60115e-06
L1CAM [NCBI] 3.60115e-06
CTSC [NCBI] 3.60115e-06
RP [NCBI] 3.54466e-06
ALAD [NCBI] 3.51168e-06
WAS [NCBI] 3.42465e-06
FGF23 [NCBI] 3.42465e-06
SRF [NCBI] 3.40916e-06
IL6 [NCBI] 3.30513e-06
pulmonary fibrosis, idiopathic [NCBI] 3.27024e-06
MDC1A [NCBI] 3.27024e-06
sialuria, finnish type [NCBI] 3.27024e-06
CNC1 [NCBI] 3.27024e-06
DAO [NCBI] 3.25749e-06
isoniazid inactivation [NCBI] 3.25749e-06
MCP [NCBI] 3.17857e-06
CYP2D6 [NCBI] 3.1772e-06
MTND1 [NCBI] 3.1772e-06
FH [NCBI] 3.1772e-06
RLBP1 [NCBI] 3.09898e-06
PROCR [NCBI] 3.02276e-06
SLC18A2 [NCBI] 2.94848e-06
LBR [NCBI] 2.87607e-06
MLC [NCBI] 2.85488e-06
hodgkin lymphoma [NCBI] 2.85488e-06
MADA [NCBI] 2.85488e-06
MADD [NCBI] 2.85488e-06
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency [NCBI] 2.85488e-06
DCC [NCBI] 2.80545e-06
DRD2 [NCBI] 2.80545e-06
NAT1 [NCBI] 2.80545e-06
CVID [NCBI] 2.59182e-06
metachromatic leukodystrophy [NCBI] 2.5764e-06
PGR [NCBI] 2.54354e-06
PKD2 [NCBI] 2.5398e-06
CMM2 [NCBI] 2.47917e-06
GTS [NCBI] 2.4178e-06
CYP19A1 [NCBI] 2.41633e-06
LQT1 [NCBI] 2.39905e-06
IRS1 [NCBI] 2.35676e-06
SPARC [NCBI] 2.29858e-06
MEN2A [NCBI] 2.21565e-06
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 2.21565e-06
GHRH [NCBI] 2.21452e-06
MELAS [NCBI] 2.13978e-06
citrullinemia, classic [NCBI] 2.13978e-06
AHC [NCBI] 2.13978e-06
NR5A1 [NCBI] 2.13195e-06
APOD [NCBI] 2.07892e-06
CCL2 [NCBI] 2.07892e-06
porphyria variegata [NCBI] 2.0429e-06
HGPS [NCBI] 2.0429e-06
INS [NCBI] 1.98908e-06
DRD4 [NCBI] 1.92688e-06
VCP [NCBI] 1.87845e-06
amyloidosis vi [NCBI] 1.8484e-06
pheochromocytoma [NCBI] 1.83383e-06
hepatocellular carcinoma [NCBI] 1.83383e-06
IL3 [NCBI] 1.83109e-06
RYR1 [NCBI] 1.69516e-06
SLC11A2 [NCBI] 1.60941e-06
RDT [NCBI] 1.5572e-06
TCOF [NCBI] 1.5572e-06
factor v deficiency [NCBI] 1.48762e-06
STAT6 [NCBI] 1.44876e-06
FMR1 [NCBI] 1.34683e-06
VHL [NCBI] 1.3371e-06
LDLR [NCBI] 1.33061e-06
SPDA1 [NCBI] 1.31219e-06
POF1 [NCBI] 1.31219e-06
HLA-A [NCBI] 1.19903e-06
BTK [NCBI] 1.19903e-06
GBA [NCBI] 1.19903e-06
ADA [NCBI] 1.09707e-06
STGD1 [NCBI] 1.09218e-06
leiomyomatosis and renal cell cancer, hereditary [NCBI] 1.09218e-06
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i [NCBI] 1.09218e-06
homocystinuria [NCBI] 1.04233e-06
SMAX1 [NCBI] 1.0418e-06
TLR4 [NCBI] 1.0007e-06
SLS [NCBI] 9.92763e-07
AIRE [NCBI] 9.01636e-07
graves disease [NCBI] 8.96862e-07
MCOPS7 [NCBI] 8.96862e-07
SDC2 [NCBI] 8.92452e-07
GH1 [NCBI] 8.75277e-07
TSD [NCBI] 7.64725e-07
VDR [NCBI] 7.4874e-07
MC1R [NCBI] 7.28646e-07
PI [NCBI] 7.13246e-07
hypertelorism with esophageal abnormality and hypospadias [NCBI] 6.92477e-07
PNMT [NCBI] 6.6719e-07
asthma, susceptibility to [NCBI] 6.64121e-07
NRG1 [NCBI] 6.6229e-07
bullous erythroderma ichthyosiformis congenita of brocq [NCBI] 6.3962e-07
PXE [NCBI] 6.21069e-07
FBN1 [NCBI] 6.00242e-07
MAOA [NCBI] 6.00242e-07
SLC6A3 [NCBI] 5.52408e-07
CLS [NCBI] 5.36656e-07
AMH [NCBI] 5.3603e-07
NF1 [NCBI] 4.74601e-07
NPM1 [NCBI] 4.54211e-07
CCM [NCBI] 4.41558e-07
AMC [NCBI] 4.41558e-07
OCP [NCBI] 4.41558e-07
HHF2 [NCBI] 4.41558e-07
FGFR3 [NCBI] 4.16105e-07
HNPP [NCBI] 3.54645e-07
GRA [NCBI] 3.54645e-07
MITF [NCBI] 3.47408e-07
IGFALS [NCBI] 3.33616e-07
CML [NCBI] 3.31893e-07
EVA [NCBI] 3.31893e-07
CMD1A [NCBI] 3.31893e-07
HCH [NCBI] 3.31893e-07
pena-shokeir syndrome, type i [NCBI] 2.89994e-07
PMD [NCBI] 2.44484e-07
SJS1 [NCBI] 2.38261e-07
PCTT [NCBI] 2.38261e-07
sandhoff disease [NCBI] 2.38261e-07
DDC [NCBI] 2.3543e-07
CMT1B [NCBI] 2.06764e-07
neuroblastoma [NCBI] 2.06764e-07
panencephalitis, subacute sclerosing [NCBI] 1.86666e-07
WFS1 [NCBI] 1.61478e-07
UCP1 [NCBI] 1.57135e-07
thyroid carcinoma, papillary [NCBI] 1.46544e-07
AGER [NCBI] 1.3246e-07
LFS1 [NCBI] 1.00608e-07
ATS [NCBI] 1.00608e-07
neuraminidase deficiency [NCBI] 1.00608e-07
CDG1A [NCBI] 1.00608e-07
KSS [NCBI] 6.97926e-08
SLC6A4 [NCBI] 6.33821e-08
LEP [NCBI] 6.18039e-08
SLC2A4 [NCBI] 6.18039e-08
TS [NCBI] 5.89301e-08
TERT [NCBI] 5.68278e-08
ABL [NCBI] 5.56082e-08
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity [NCBI] 5.47927e-08
HYPP [NCBI] 5.47927e-08
PDS [NCBI] 5.47927e-08
CTNS [NCBI] 5.47927e-08
mucolipidosis ii [NCBI] 5.47927e-08
FAAH [NCBI] 5.11696e-08
ACADM [NCBI] 3.91782e-08
ALK [NCBI] 3.68321e-08
TRPS2 [NCBI] 2.32386e-08
HHF1 [NCBI] 2.32386e-08
PMP22 [NCBI] 1.95031e-08
SOD2 [NCBI] 1.66137e-08
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 1.08653e-08
MAG [NCBI] 6.00069e-09
hypophosphatemic rickets, x-linked dominant [NCBI] 5.21464e-09
PJS [NCBI] 4.25975e-09
JMML [NCBI] 2.12747e-09
CNTF [NCBI] 1.00953e-09
PPR [NCBI] 6.26568e-10
CDK4 [NCBI] 1.86609e-11



Database Center for Life Science